NuGen Medical Devices Inc. (TSXV:NGMD)

Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
At close: Feb 6, 2026
Market Cap6.81M -67.1%
Revenue (ttm)589.43K -22.7%
Net Income-2.12M
EPS-0.01
Shares Out227.04M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Average Volume34,593
Open0.0300
Previous Close0.0300
Day's Range0.0300 - 0.0300
52-Week Range0.0300 - 0.0950
Beta2.04
RSI43.52
Earnings DateApr 30, 2026

About NuGen Medical Devices

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered i... [Read more]

Sector Healthcare
CEO Lin Liang
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NGMD
Full Company Profile

Financial Performance

In 2024, NuGen Medical Devices's revenue was 1.01 million, an increase of 204.73% compared to the previous year's 331,403. Losses were -5.23 million, -44.18% less than in 2023.

Financial Statements